Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Imaging and Radioligand Therapy

Authors

Institutions

Publication Details

Journal
ACS Chemical Biology
Published
2026-07-27
DOI
https://doi.org/10.1021/acschembio.6c00253
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Imaging and Radioligand Therapy

E. E. Tereshatov, Steven Schultz, Riccardo Muzzioli, Jonathan D. Burns et al.
ACS Chemical Biology
PARP inhibition in cancer therapy
article

Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Imaging and Radioligand Therapy

E. E. Tereshatov, Steven Schultz, Riccardo Muzzioli, Jonathan D. Burns, Seth T. Gammon, Federica Pisaneschi, David Piwnica‐Worms, L. McCann, Raffaele Bellini Puglielli, Lauren McIntosh, A E Napoli, Sherry Yennello, Gabriel Tabacaru, Margie N. Sutton
article en

Abstract

No abstract available for this paper.
ACS Chemical Biology
The University of Texas MD Anderson Cancer Center (US), Mitchell Institute (US), University of Alabama at Birmingham (US), Division of Chemistry (US), Cyclotron (Netherlands) (NL), Texas A&M University (US)
U.S. Department of Energy, University of Texas MD Anderson Cancer Center, National Cancer Institute
Openalex Percentile: Top 12%
PARP inhibition in cancer therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.